UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                             Washington, DC 20549


                                  FORM 12b-25


                            NOTIFICATION OF LATE FILING          SEC File Number
                                                                          0-5099
                                                                          ------
                                                                    CUSIP Number
                                                                     532168 10 1

(Check One): [X]Form 10-KSB [_]Form 11-K [_]Form 20-F [_]Form 10-Q [_]Form N-SAR

             For Period Ended: May 31, 2001

             [_]   Transition Report on Form 10-K
             [_]   Transition Report on Form 20-F
             [_]   Transition Report on Form 11-K
             [_]   Transition Report on Form 10-Q
             [_]   Transition Report on Form N-SAR
             For the Transition Period Ended:__________________________


Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.


If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:
- -----------------------------------------------------------

PART I - REGISTRANT INFORMATION

     LIFE SCIENCES, INC.
- -----------------------------------------------------------
Full Name of Registrant


- -----------------------------------------------------------
Former Name if Applicable

     2900 - 72ND STREET NORTH
- -----------------------------------------------------------
Address of Principal Executive Office (Street and Number)

     ST. PETERSBURG, FLORIDA 33710
- -----------------------------------------------------------
City, State and Zip Code


PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed.  (Check box if appropriate.)

     [X]  (a)  The reasons described in reasonable detail in Part III of this
          form could not be eliminated without unreasonable effort or expense;

     [X]  (b)  The subject annual report, semi-annual report, transition report
          on Form 10-K, Form 20-F, Form 11-K, or Form N-SAR, or portion thereof,
          will be filed on or before the 15th calendar day following the
          prescribed due date; or the subject quarterly report or transition
          report on Form 10-Q, or portion thereof, will be filed on or before
          the fifth calendar day following the prescribed due date; and

     [_]  (c)  The accountant's statement or other exhibit required by Rule
          12b-25(c) has been attached, if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report portion thereof, could not be filed within the
prescribed time period. (Attach Extra Sheets if Needed.)


Life Sciences, Inc. (the "Company") cannot file its Form 10-KSB for the year
ended May 31, 2001 within the prescribed time period because of other business
demands on the limited personnel of the Company, which personnel are responsible
for the preparation of supporting information and detail necessary to the
financial and the non-financial portions of the report. These factors have
delayed the completion of the audit of the Company's financial statements, and
the completion of the financial and the non-financial portions of the report.


PART IV - OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
     notification:

          ALEX A. BURNS             727                 345-9371
          -------------         -----------          ----------------
             (Name)             (Area Code)         (Telephone Number)

(2)  Have all other periodic reports required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter period that the
     registrant was required to file such report(s) been filed?  If the answer
     is no, identify report(s).        [_] Yes  [X] No
                                       Forms 10-QSB for fiscal year 2001

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding period for the last fiscal year will be reflected by the
     earnings statements to be included in the subject report or portion
     thereof?                          [_] Yes  [X] No

If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

                                       2


                              LIFE SCIENCES, INC.
             ------------------------------------------------------
                 (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.


Date  AUGUST 28, 2001            By: /s/ ALEX A. BURNS
     -----------------               ----------------------------
                                     Alex A. Burns, Vice President and Secretary

INSTRUCTION:  The form may be signed by an executive officer of the registrant
or by any other duly authorized representative.  The name and title of the
person signing the form shall be typed or printed beneath the signature.  If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                   ATTENTION
  Intentional misstatements or omissions of fact constitute Federal Criminal
                       Violations (See 18 U.S.C. 1001).


                             GENERAL INSTRUCTIONS

1.   This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
     Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed original and four conformed copies of this form and amendments
     thereto must be completed and filed with the Securities and Exchange
     Commission, Washington, DC 20549, in accordance with Rule 0-3 of the
     General Rules and Regulations under the Act.  The information contained in
     or filed with the form will be made a matter of public record in the
     Commission files.

3.   A manually signed copy of the form and amendments thereto shall be filed
     with each national securities exchange on which any class of securities of
     the registrant is registered.

4.   Amendments to the notifications must also be filed on Form 12b-25 but need
     not restate information that has been correctly furnished.  The form shall
     be clearly identified as an amendment notification.

5.   Electronic Filers.  This form shall not be used by electronic filers unable
     to timely file a report solely due to electronic difficulties.  Filers
     unable to submit a report within the time period prescribed due to
     difficulties in electronic filing should comply with either Rule 201 or
     Rule 202 of Regulation S-T ((S)232.201 or (S)232.202 of this chapter) or
     apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation
     S-T ((S)232.13(b) of this chapter).

                                       3